Evidence & Research Status
Educational only — this reflects what published research explores, not medical advice or a recommendation to take anything. Where benefits are mentioned, they describe findings in research models…
Evidence Level reflects the general state of published research for this compound category and is not a claim about the safety, efficacy, or approval status of any product sold on this site. All compounds are offered strictly for research use.
By Charles Fowler, Founder of Portal to Wellness · Last reviewed: June 2026 · ~8 min read
Educational only — this reflects what published research explores, not medical advice or a recommendation to take anything. Where benefits are mentioned, they describe findings in research models, not promised outcomes in people. I’m a founder who reads this literature daily, not a physician. Please consult a qualified healthcare professional before changing your health routine.
If you already know what NAD+ is, the natural next question is: why does anyone care? Why has a single coenzyme become the centerpiece of longevity research labs and biohacker conversations alike? The short answer is that NAD+ sits at the crossroads of two things humans care about most — energy and aging — and the research exploring those connections is genuinely interesting. Here’s the honest version of what’s being studied, and where the evidence stands.
Key Takeaways
- NAD+ is a coenzyme essential to virtually every cell’s energy production process.
- Its natural decline with age is one of the most consistently reported findings in aging research.
- This decline is part of why the longevity research field has focused heavily on NAD+.
- Current research has real, honest limits — NAD+ research doesn’t yet prove reversal of aging.
1. Cellular energy — NAD+ is non-negotiable
This is the most established role. NAD+ is an essential electron carrier in the mitochondria: in its reduced form (NADH) it feeds electrons into Complex I of the electron transport chain, kicking off the cascade that produces the vast majority of your cells’ ATP — the energy currency of life. No NAD+, no efficient energy production. This isn’t speculative; it’s textbook biochemistry. The research question is what happens to that energy machinery as NAD+ availability changes with age.
2. The aging connection — NAD+ declines, and that matters
A consistent finding across the literature is that cellular NAD+ levels fall substantially with age — by some measures, a 60-year-old may have roughly half the NAD+ of a 20-year-old.[1] What makes this more than a curiosity is what depends on NAD+. Two enzyme families in particular:
- Sirtuins — a family of seven proteins (SIRT1–7) that regulate DNA repair, inflammation, and metabolism. They depend entirely on NAD+ to function. SIRT1 and SIRT3 get the most longevity-research attention.[2]
- PARPs — enzymes that consume NAD+ during DNA repair.
The research narrative goes like this: as NAD+ declines, sirtuin and PARP activity is constrained, which is associated in studies with several of the established hallmarks of aging — mitochondrial dysfunction, genomic instability, cellular senescence, and chronic low-grade inflammation.[2][3] That’s why NAD+ is studied as a potential lever on the aging process rather than a single symptom.
3. Why the longevity field is specifically interested
Restoring NAD+ — usually via precursors like NMN and NR — is studied for whether it can support mitochondrial function and sirtuin activity in aging models. In animal studies, raising NAD+ has been associated with improvements in measures of metabolism, mitochondrial health, and certain markers of healthy aging. NAD+ also appears in regenerative-medicine research for its role in cellular energy during repair.[3]
It’s frequently studied alongside other longevity compounds — for example MOTS-c (a mitochondrial-derived peptide) and other members of our Mitochondrial & Longevity collection.
The honest limits
Here’s where I keep myself honest, and you should too. The fact that NAD+ declines with age and correlates with aging features does not prove that raising it reverses or slows aging in people. Human studies show precursors can raise blood NAD+ and are generally well tolerated short-term, but whether that produces durable, meaningful health or longevity benefits in humans is not yet settled — most trials are small and short. We cover the safety side specifically in Is NAD+ Safe? The responsible framing: NAD+ is one of the most promising and best-justified areas in longevity research, and also one where the marketing routinely outruns the evidence.
What this means if you’re researching the category
The interest in NAD+ is well-founded at the level of mechanism — its role in energy and the sirtuin/aging axis is real and important. The open question is translation to human outcomes. If you’re exploring research compounds in this space, prioritize quality and transparency (third-party testing, a batch COA), read primary research over marketing, and treat “anti-aging cure” claims with skepticism.
📄 Free download: NAD+ & Longevity Starter Guide
A plain-English starter guide to NAD+ — what it is, why it matters for energy and aging, the NMN-vs-NR question, and what the evidence does and does not show. Enter your email and we’ll send it straight to your inbox — no spam, unsubscribe anytime.
Frequently asked questions
What are the studied benefits of NAD+?
In research models, NAD+ is central to mitochondrial energy production and is required for sirtuin and PARP enzymes involved in DNA repair, metabolism, and inflammation control. These are research findings, not promised human outcomes.
Why do NAD+ levels matter for aging?
NAD+ declines with age, and that decline is associated in studies with reduced sirtuin activity and several hallmarks of aging, including mitochondrial dysfunction and chronic inflammation. Whether restoring NAD+ slows aging in humans is still being studied.
How is NAD+ connected to energy?
NAD+/NADH is an essential electron carrier in the mitochondrial electron transport chain that drives ATP (cellular energy) production — a well-established biochemical role.
Does raising NAD+ make you live longer?
Not proven in humans. Animal and early human data are encouraging, but large, long-term human trials are still needed. Be cautious of marketing that claims otherwise.
Related reading
What Is NAD+? · NMN vs NR · Is NAD+ Safe?
About the author
Charles Fowler is the founder and researcher behind Portal to Wellness. After a career in management consulting, he spent the past two years immersed in the wellness and research-compound space — sourcing products, vetting suppliers, and reading the primary literature daily. He isn’t a physician or a scientist, and he’ll tell you so. His goal is to translate what the research actually says into plain English so customers can make informed decisions.
How we research our content
Our Research Library articles are written from peer-reviewed scientific literature and reputable references, and we date every article. We don’t make therapeutic, dosing, or “cure” claims, and we flag clearly where the science is still unsettled.
References
- Bhasin S, Seals D, Migaud M, Musi N, Baur JA. Nicotinamide Adenine Dinucleotide in Aging Biology: Potential Applications and Many Unknowns. Endocrine Reviews. 2023;44(6):1047-1073. https://pubmed.ncbi.nlm.nih.gov/37364580/
- Sirtuins, NAD+, DNA repair and mitochondrial function in aging. (Review.) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8656451/
- The Role of NAD+ in Regenerative Medicine. https://pmc.ncbi.nlm.nih.gov/articles/PMC9512238/
📚 Part of our Energy & Longevity research guide.
NAD+ — Research-Grade, Research Use Only
This article is for informational and educational purposes only. It is not medical advice and does not describe the diagnosis, treatment, cure, or prevention of any disease. Portal to Wellness products are sold for research purposes only. Always consult a qualified healthcare professional before making changes to your health routine.
Amounts used in the published research
Human studies — injected NAD+
| Study | Amount | Route | Schedule | n | Finding |
|---|---|---|---|---|---|
| Grant 2019 | 750 mg | IV, ~2 mg/min | Single 6-hour infusion | 8 treated | Plasma NAD+ did not rise at all for the first 2 hours, then peaked ~+398% at 6 h |
| Reyna 2026 (retrospective chart review) | 500 mg | IV | 4 consecutive days | 6 | Mean infusion time 97 min; GI symptoms, raised heart rate, chest pressure during infusion |
| Hawkins 2024 (preprint, not peer-reviewed) | 500 mg | IV | Single infusion | 10 + 8 | Whole-blood NAD+ unchanged at 3 h, +2% at 24 h; infusions took 1.6–3 hours to tolerate |
| Registered Chinese trials (“Coenzyme I for Injection”) | 5–100 mg/day | IV or IM | 7–21 days | — | Recruiting or unknown status; no published results |
Tolerability is the recurring theme: flushing, chest pressure, GI upset and raised heart rate are why a 500 mg infusion is spread over one to four hours rather than pushed.
Oral precursors — far better studied, and not interchangeable
| Compound | Published range | Duration |
|---|---|---|
| NMN (oral) | 100 – 1,250 mg/day | Single dose to 12 weeks, consistently well tolerated |
| NR (oral) | 100 – 2,000 mg/day | Single dose to 12 weeks; blood NAD+ rose +22% / +51% / +142% at 100 / 300 / 1,000 mg/day |
Animal studies of injected NAD+
Reported ranges span roughly 10–250 mg/kg depending on model and route: 10–20 mg/kg IV in rat cardiac ischemia, 75 mg/kg IP in spinal cord injury, 250 mg/kg/day IP in a mouse optic neuritis model. Note that many papers labelled “NAD” actually used NADH, nicotinamide, NMN or NR — check the molecule before relying on any figure.
Sources
Grant R et al. Front Aging Neurosci 2019, 750 mg IV PK — PMC6751327
Reyna K et al. Front Aging 2026, 500 mg IV chart review — PMID 41704678
Hawkins et al. 2024, medRxiv preprint — medRxiv (NCT06382688)
Conze D et al. Sci Rep 2019, oral NR dose response — PMID 31278280
Yoshino M et al. Science 2021, oral NMN 250 mg/day — PMID 33888596
Zhai X et al. Am J Transl Res 2016, rat IV NAD+ — PMC5009387